In today’s ACT Brief, we examine how the CRA role is transforming alongside modern clinical trial technology, review the ...
In this Q&A, John Kirk, principal regulatory specialist at Veristat, explains how the FDA’s Commissioner’s National Priority ...
The FDA has granted accelerated approval to Otsuka’s Voyxact for adults with primary IgAN at risk of disease progression, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback